Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	brain-derived neurotrophic factor binding	NTRK2 FSTL4	1.36e-04	4	96	2	GO:0048403
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 NFATC3 NFE2L1 GLI1 GLI2 ZNF347 TBR1 ZNF426 NR1D2	2.74e-04	1244	96	16	GO:0000978
GeneOntologyMolecularFunction	N,N-dimethylaniline monooxygenase activity	FMO3 FMO6P	3.39e-04	6	96	2	GO:0004499
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 NFATC3 NFE2L1 GLI1 GLI2 ZNF347 TBR1 ZNF426 NR1D2	3.48e-04	1271	96	16	GO:0000987
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 NFATC3 NFE2L1 GLI1 GLI2 ZNF347 TAF1 TBR1 ZNF426 NR1D2	5.44e-04	1459	96	17	GO:0000977
GeneOntologyBiologicalProcess	notochord regression	GLI1 GLI2	1.88e-05	2	90	2	GO:0060032
GeneOntologyBiologicalProcess	central nervous system neuron differentiation	TOX NTRK2 ATXN2 NFE2L1 GLI2 TBR1 HERC1	4.62e-05	217	90	7	GO:0021953
GeneOntologyBiologicalProcess	cerebellar cortex morphogenesis	ATXN2 GLI1 GLI2 HERC1	5.69e-05	48	90	4	GO:0021696
GeneOntologyCellularComponent	GLI-SUFU complex	GLI1 GLI2	1.24e-04	4	96	2	GO:1990788
Domain	Prot_kin_PKC_delta	PRKCD PRKCQ	1.53e-04	4	95	2	IPR014376
Domain	-	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 GLI1 GLI2 ZNF347 ZNF426	1.67e-04	679	95	12	3.30.160.60
Domain	zf-C2H2	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 GLI1 GLI2 ZNF347 ZNF426	2.02e-04	693	95	12	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 GLI1 GLI2 ZNF347 ZNF426	2.05e-04	694	95	12	IPR013087
Domain	ZINC_FINGER_C2H2_2	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 GLI1 GLI2 ZNF347 ZNF426	5.55e-04	775	95	12	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 GLI1 GLI2 ZNF347 ZNF426	5.68e-04	777	95	12	PS00028
Domain	Znf_C2H2-like	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 GLI1 GLI2 ZNF347 ZNF426	7.02e-04	796	95	12	IPR015880
Domain	Znf_C2H2	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 GLI1 GLI2 ZNF347 ZNF426	7.75e-04	805	95	12	IPR007087
Domain	ZnF_C2H2	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 GLI1 GLI2 ZNF347 ZNF426	8.00e-04	808	95	12	SM00355
Domain	Pkinase_C	CDC42BPA PRKCD PRKCQ	8.74e-04	37	95	3	IPR017892
Domain	zf-C2H2_6	ZNF140 ZNF521 ZNF317 ZNF181 ZNF551 ZNF16 ZNF426	1.11e-03	314	95	7	PF13912
Domain	Pkinase_C	CDC42BPA PRKCD PRKCQ	1.27e-03	42	95	3	PF00433
Domain	ZnF_BED	ZNF181 ZNF426	1.37e-03	11	95	2	SM00614
Domain	-	DCAF1 COPA FSTL4 MAPK8IP3 HIRA HERC1 SPAG16	1.55e-03	333	95	7	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	DCAF1 COPA FSTL4 MAPK8IP3 HIRA HERC1 SPAG16	1.61e-03	335	95	7	IPR015943
Domain	ABC_A	ABCA1 ABCA13	1.63e-03	12	95	2	IPR026082
Domain	Znf_BED	ZNF181 ZNF426	1.63e-03	12	95	2	IPR003656
Domain	ABC_tran	ABCC4 ABCA1 ABCA13	1.87e-03	48	95	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCC4 ABCA1 ABCA13	1.87e-03	48	95	3	PS50893
Domain	ABC_TRANSPORTER_1	ABCC4 ABCA1 ABCA13	1.98e-03	49	95	3	PS00211
Domain	-	HLA-C NTRK2 FSTL4 PTPRU IGFBPL1 PXDN NFATC3 KIR3DL1 KIR3DS1 USH2A	1.99e-03	663	95	10	2.60.40.10
Domain	ABC_transporter-like	ABCC4 ABCA1 ABCA13	2.10e-03	50	95	3	IPR003439
Domain	KRAB	ZNF140 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF347 ZNF426	2.34e-03	358	95	7	PS50805
Domain	KRAB	ZNF140 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF347 ZNF426	2.34e-03	358	95	7	PF01352
Domain	KRAB	ZNF140 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF347 ZNF426	2.77e-03	369	95	7	SM00349
Domain	KRAB	ZNF140 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF347 ZNF426	2.81e-03	370	95	7	IPR001909
Domain	AGC-kinase_C	CDC42BPA PRKCD PRKCQ	2.91e-03	56	95	3	IPR000961
Domain	AGC_KINASE_CTER	CDC42BPA PRKCD PRKCQ	2.91e-03	56	95	3	PS51285
Domain	S_TK_X	CDC42BPA PRKCD PRKCQ	2.91e-03	56	95	3	SM00133
Domain	Disintegrin_CS	ADAM7 ADAM30	2.93e-03	16	95	2	IPR018358
Domain	C1_1	CDC42BPA PRKCD PRKCQ	3.06e-03	57	95	3	PF00130
Domain	Ig-like_fold	HLA-C NTRK2 FSTL4 PTPRU IGFBPL1 PXDN NFATC3 KIR3DL1 KIR3DS1 USH2A	3.13e-03	706	95	10	IPR013783
Domain	CarboxyPept-like_regulatory	TENM2 CPXM1	3.31e-03	17	95	2	IPR008969
Domain	ADAM_CR	ADAM7 ADAM30	3.71e-03	18	95	2	PF08516
Domain	WD40_repeat_dom	DCAF1 COPA MAPK8IP3 HIRA HERC1 SPAG16	4.09e-03	297	95	6	IPR017986
Domain	Ig-like_dom	HLA-C NTRK2 FSTL4 PTPRU IGFBPL1 PXDN KIR3DL1 KIR3DS1	4.11e-03	503	95	8	IPR007110
Domain	ZF_DAG_PE_1	CDC42BPA PRKCD PRKCQ	4.24e-03	64	95	3	PS00479
Domain	ZF_DAG_PE_2	CDC42BPA PRKCD PRKCQ	4.24e-03	64	95	3	PS50081
Domain	C1	CDC42BPA PRKCD PRKCQ	4.43e-03	65	95	3	SM00109
Domain	-	ADAM7 ADAM30	4.58e-03	20	95	2	4.10.70.10
Domain	PE/DAG-bd	CDC42BPA PRKCD PRKCQ	4.63e-03	66	95	3	IPR002219
Domain	Disintegrin	ADAM7 ADAM30	5.05e-03	21	95	2	PF00200
Domain	DAG/PE-bd	PRKCD PRKCQ	5.05e-03	21	95	2	IPR020454
Domain	DISIN	ADAM7 ADAM30	5.05e-03	21	95	2	SM00050
Domain	Quino_amine_DH_bsu	FSTL4 TENM2	5.53e-03	22	95	2	IPR011044
Domain	Kazal_1	FSTL4 IGFBPL1	5.53e-03	22	95	2	PF00050
Domain	IG	NTRK2 FSTL4 PTPRU IGFBPL1 PXDN KIR3DL1 KIR3DS1	5.68e-03	421	95	7	SM00409
Domain	Ig_sub	NTRK2 FSTL4 PTPRU IGFBPL1 PXDN KIR3DL1 KIR3DS1	5.68e-03	421	95	7	IPR003599
Pubmed	The stem cell-associated transcription co-factor, ZNF521, interacts with GLI1 and GLI2 and enhances the activity of the Sonic hedgehog pathway.	ZNF521 GLI1 GLI2	8.66e-08	4	98	3	31558698
Pubmed	Killer cell immunoglobulin-like receptor genotypes in Japanese patients with type 1 diabetes.	HLA-C KIR3DL1 KIR3DS1	2.16e-07	5	98	3	17990989
Pubmed	HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.	HLA-C KIR3DL1 KIR3DS1	1.20e-06	8	98	3	27649529
Pubmed	The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis.	GLI1 GLI2 TBR1	1.80e-06	9	98	3	11748155
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	HLA-C KIR3DL1 KIR3DS1	1.80e-06	9	98	3	18340360
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	HLA-C KIR3DL1 KIR3DS1	4.69e-06	12	98	3	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	HLA-C KIR3DL1 KIR3DS1	4.69e-06	12	98	3	19181658
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	HLA-C KIR3DL1 KIR3DS1	4.69e-06	12	98	3	20137308
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	HLA-C KIR3DL1 KIR3DS1	6.08e-06	13	98	3	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	HLA-C KIR3DL1 KIR3DS1	6.08e-06	13	98	3	19120281
Pubmed	Relative Levels of Gli1 and Gli2 Determine the Response of Ventral Neural Stem Cells to Demyelination.	GLI1 GLI2	7.86e-06	2	98	2	33125874
Pubmed	Maintenance of Taste Organs Is Strictly Dependent on Epithelial Hedgehog/GLI Signaling.	GLI1 GLI2	7.86e-06	2	98	2	27893742
Pubmed	Protein kinase Cdelta regulates antigen receptor-induced lytic granule polarization in mouse CD8+ CTL.	PRKCD PRKCQ	7.86e-06	2	98	2	17548619
Pubmed	JIP3 regulates neuronal radial migration by mediating TrkB axonal anterograde transport in the developing cerebral cortex.	NTRK2 MAPK8IP3	7.86e-06	2	98	2	28259553
Pubmed	Role of GLI1 and NDRG1 in Increased Resistance to Apoptosis Induction.	NDRG1 GLI1	7.86e-06	2	98	2	26349604
Pubmed	No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	19874556
Pubmed	Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	27708262
Pubmed	Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.	HLA-C KIR3DL1	7.86e-06	2	98	2	17950922
Pubmed	Investigation of killer cell immunoglobulin-like receptor gene diversity in KIR3DL1 and KIR3DS1 in a transplant population.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	18331531
Pubmed	Decreased iKIR-HLA C Pair Confers Worse Clinical Outcomes for Patients With Myeloid Disease Receiving Antithymocyte Globulin-Based Haploidentical Hematopoietic Stem Cell Transplantation.	HLA-C KIR3DL1	7.86e-06	2	98	2	33633734
Pubmed	Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	16805919
Pubmed	Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.	GLI1 GLI2	7.86e-06	2	98	2	25745035
Pubmed	Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	19211742
Pubmed	Unique and overlapping GLI1 and GLI2 transcriptional targets in neoplastic chondrocytes.	GLI1 GLI2	7.86e-06	2	98	2	30695055
Pubmed	Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	35192601
Pubmed	Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	37647275
Pubmed	Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma.	GLI1 GLI2	7.86e-06	2	98	2	12165851
Pubmed	Association of the KIR3DS1013 and KIR3DL1004 alleles with susceptibility to ankylosing spondylitis.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	20131260
Pubmed	The GLI gene is a member of the Kruppel family of zinc finger proteins.	GLI1 GLI2	7.86e-06	2	98	2	2832761
Pubmed	GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.	GLI1 GLI2	7.86e-06	2	98	2	32766732
Pubmed	Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	25112829
Pubmed	Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	17694054
Pubmed	A Critical Function for the Transcription Factors GLI1 and GLI2 in the Proliferation and Survival of Human Mast Cells.	GLI1 GLI2	7.86e-06	2	98	2	35251038
Pubmed	GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter.	GLI1 GLI2	7.86e-06	2	98	2	15175043
Pubmed	[Expression and clinical significances of hedgehog signaling pathway in non-Hodgkin's lymphoma].	GLI1 GLI2	7.86e-06	2	98	2	22040957
Pubmed	Age-related macular degeneration is associated with the HLA-Cw*0701 Genotype and the natural killer cell receptor AA haplotype.	HLA-C KIR3DL1	7.86e-06	2	98	2	18515573
Pubmed	Contribution of functional KIR3DL1 to ankylosing spondylitis.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	20818412
Pubmed	[Gene KIR in match with HLA-Cw impacts on NK cell cytotoxicity].	HLA-C KIR3DL1	7.86e-06	2	98	2	19549379
Pubmed	A method for killer-cell immunoglobulin-like receptor (KIR) 3DL1/3DS1 genotyping using DNA recovered from frozen plasma.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	23524032
Pubmed	The oncogenic GLI transcription factors facilitate keratinocyte survival and transformation upon exposure to genotoxic agents.	GLI1 GLI2	7.86e-06	2	98	2	23792444
Pubmed	Allele diversity of the killer cell immunoglobulin-like receptors KIR3DL1/S1 and the combination with their HLA ligands in Mexican Mestizos from Mexico City.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	30365992
Pubmed	Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	17182560
Pubmed	Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	19008943
Pubmed	Acrolein-induced atherogenesis by stimulation of hepatic flavin containing monooxygenase 3 and a protection from hydroxytyrosol.	ABCA1 FMO3	7.86e-06	2	98	2	29953618
Pubmed	Protein kinase inhibitor SU6668 attenuates positive regulation of Gli proteins in cancer and multipotent progenitor cells.	GLI1 GLI2	7.86e-06	2	98	2	24418624
Pubmed	Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway.	ABCA1 PRKCD	7.86e-06	2	98	2	17325386
Pubmed	HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	19386717
Pubmed	Formalin evokes calcium transients from the endoplasmatic reticulum.	TRPA1 ATP2A1	7.86e-06	2	98	2	25875358
Pubmed	Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	28942035
Pubmed	The profile of KIR3DL1 and KIR3DS1 alleles in an African American population resembles that found in African populations.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	20230527
Pubmed	Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	11098931
Pubmed	Protein kinase Cdelta negatively regulates hedgehog signaling by inhibition of Gli1 activity.	GLI1 PRKCD	7.86e-06	2	98	2	19015273
Pubmed	Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes.	GLI1 GLI2	7.86e-06	2	98	2	16434164
Pubmed	Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes.	KIR3DL1 KIR3DS1	7.86e-06	2	98	2	19411600
Pubmed	A significant effect of the killer cell immunoglobulin-like receptor ligand human leucocyte antigen-C on fibrosis progression in chronic C hepatitis with or without liver transplantation.	HLA-C KIR3DL1	7.86e-06	2	98	2	26717049
Pubmed	ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative Neoplasms.	TET2 ABCA1	7.86e-06	2	98	2	32160545
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	HLA-C KIR3DL1 KIR3DS1	9.63e-06	15	98	3	19850842
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	HLA-C KIR3DL1 KIR3DS1	9.63e-06	15	98	3	20356536
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	HLA-C KIR3DL1 KIR3DS1	9.63e-06	15	98	3	19493232
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	HLA-C KIR3DL1 KIR3DS1	9.63e-06	15	98	3	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	HLA-C KIR3DL1 KIR3DS1	9.63e-06	15	98	3	19326408
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	HLA-C KIR3DL1 KIR3DS1	1.18e-05	16	98	3	20652381
Pubmed	No association of KIR genes with Behcet's disease.	HLA-C KIR3DL1 KIR3DS1	1.18e-05	16	98	3	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	HLA-C KIR3DL1 KIR3DS1	1.18e-05	16	98	3	18643961
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	HLA-C KIR3DL1 KIR3DS1	1.18e-05	16	98	3	20210919
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	HLA-C KIR3DL1 KIR3DS1	1.43e-05	17	98	3	19968064
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	HLA-C KIR3DL1 KIR3DS1	1.43e-05	17	98	3	19032228
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	HLA-C KIR3DL1 KIR3DS1	1.43e-05	17	98	3	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	HLA-C KIR3DL1 KIR3DS1	1.43e-05	17	98	3	20483367
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	HLA-C KIR3DL1 KIR3DS1	1.43e-05	17	98	3	19169284
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	HLA-C KIR3DL1 KIR3DS1	1.72e-05	18	98	3	19630074
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	HLA-C KIR3DL1 KIR3DS1	1.72e-05	18	98	3	19046302
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	HLA-C KIR3DL1 KIR3DS1	1.72e-05	18	98	3	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	HLA-C KIR3DL1 KIR3DS1	1.72e-05	18	98	3	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	HLA-C KIR3DL1 KIR3DS1	1.72e-05	18	98	3	19846535
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	HLA-C KIR3DL1 KIR3DS1	1.72e-05	18	98	3	20210918
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	HLA-C KIR3DL1 KIR3DS1	2.03e-05	19	98	3	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	HLA-C KIR3DL1 KIR3DS1	2.03e-05	19	98	3	18778326
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	HLA-C KIR3DL1 KIR3DS1	2.03e-05	19	98	3	20600442
Pubmed	APC sets the Wnt tone necessary for cerebral cortical progenitor development.	GLI1 GLI2 TBR1	2.03e-05	19	98	3	28916710
Pubmed	alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway.	GLI1 GLI2 TBR1	2.03e-05	19	98	3	16543460
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	HLA-C KIR3DL1 KIR3DS1	2.03e-05	19	98	3	18848853
Pubmed	Direct repression of anoctamin 1 (ANO1) gene transcription by Gli proteins.	GLI1 GLI2	2.35e-05	3	98	2	30802137
Pubmed	Fuzzy modeling reveals a dynamic self-sustaining network of the GLI transcription factors controlling important metabolic regulators in adult mouse hepatocytes.	GLI1 GLI2	2.35e-05	3	98	2	26010061
Pubmed	GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas.	GLI1 GLI2	2.35e-05	3	98	2	28342001
Pubmed	KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.	KIR3DL1 KIR3DS1	2.35e-05	3	98	2	24059286
Pubmed	The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer.	GLI1 GLI2	2.35e-05	3	98	2	30382189
Pubmed	Effect of Rab23 on the proliferation and apoptosis in breast cancer.	GLI1 GLI2	2.35e-05	3	98	2	26238143
Pubmed	20-αHydroxycholesterol, an oxysterol in human breast milk, reverses mouse neonatal white matter injury through Gli-dependent oligodendrogenesis.	GLI1 GLI2	2.35e-05	3	98	2	37541211
Pubmed	Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.	GLI1 GLI2	2.35e-05	3	98	2	26193634
Pubmed	The mechanism of epithelial-mesenchymal transition induced by TGF-β1 in neuroblastoma cells.	GLI1 GLI2	2.35e-05	3	98	2	28393230
Pubmed	Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.	HLA-C KIR3DL1	2.35e-05	3	98	2	20574122
Pubmed	Protein kinase C βII and δ/θ play critical roles in bone morphogenic protein-4-stimulated osteoblastic differentiation of MC3T3-E1 cells.	PRKCD PRKCQ	2.35e-05	3	98	2	20971075
Pubmed	Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype.	KIR3DL1 KIR3DS1	2.35e-05	3	98	2	11859120
Pubmed	A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle.	PRKCD PRKCQ	2.35e-05	3	98	2	1508194
Pubmed	Targeted sequencing identifies genetic polymorphisms of flavin-containing monooxygenase genes contributing to susceptibility of nicotine dependence in European American and African American.	FMO3 FMO6P	2.35e-05	3	98	2	28413702
Pubmed	Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication.	DCAF1 TET2	2.35e-05	3	98	2	29883611
Pubmed	Structural insight into the mutual recognition and regulation between Suppressor of Fused and Gli/Ci.	GLI1 GLI2	2.35e-05	3	98	2	24217340
Pubmed	Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies.	KIR3DL1 KIR3DS1	2.35e-05	3	98	2	17301953
Pubmed	Gli family members are differentially expressed during the mitotic phase of spermatogenesis.	GLI1 GLI2	2.35e-05	3	98	2	9178901
Cytoband	1p36.13	KLHDC7A PADI3 MICOS10	2.41e-04	56	98	3	1p36.13
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF140 ZNF521 ZKSCAN7 ZNF317 ZNF181 ZNF551 ZNF16 ZNF594 GLI1 GLI2 ZNF347 ZNF426	2.79e-05	718	73	12	28
GeneFamily	C2 domain containing protein kinases	PRKCD PRKCQ	7.09e-04	10	73	2	835
GeneFamily	ATP binding cassette subfamily A	ABCA1 ABCA13	1.42e-03	14	73	2	805
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR3DL1 KIR3DS1	2.36e-03	18	73	2	620
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NTRK2 FSTL4 IGFBPL1 PXDN	4.09e-03	161	73	4	593
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCC4 TRPA1 CSMD2 PXDN SCUBE2 DSE	3.54e-06	188	97	6	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	ABCA1 IL17A GPR183 NDRG1 DSE NR1D2	4.24e-06	194	97	6	4547b57669be5d4f0de55175802ee04372288a6a
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TOX RASGEF1A ZKSCAN7 GPR183 CORIN	2.72e-05	161	97	5	140b3c7077947c541cff54f6754e2df968345f4d
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TOX RASGEF1A ZKSCAN7 GPR183 CORIN	2.81e-05	162	97	5	16f9fbcaa0093ffc5a2a5e32db6040e2cb519d47
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PCSK5 ZNF594 PXDN KIR3DL1 L3MBTL4	2.89e-05	163	97	5	6c4d4c55fc8a731acca13c1ba7287f238a9d81e0
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor\|lymph-node_spleen / Manually curated celltypes from each tissue	CDC42BPA ZNF521 PXDN CPXM1 PLCH1	3.06e-05	165	97	5	7b992843bd8ef92a7a76b1d681fa84efde6f5bdd
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK5 TOX PTPRU PXDN TBR1	4.52e-05	179	97	5	7954c0026754ab869b88ab7feb13c2f27d6e272d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TOX FSTL4 NDRG1 SCNN1G SPAG16	4.64e-05	180	97	5	023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE9A PI16 IGFBPL1 GLI1 GLI2	4.89e-05	182	97	5	904804813849b7f7f716ba1554d33b07bc0a701e
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE9A PI16 IGFBPL1 GLI1 GLI2	4.89e-05	182	97	5	5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4
ToppCell	343B-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PTPRU ZNF317 POLR3B GLI1 CPXM1	5.28e-05	185	97	5	1b8e3ddb91797f84e4b15d2457b0c008e5be50db
ToppCell	343B-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PTPRU ZNF317 POLR3B GLI1 CPXM1	5.28e-05	185	97	5	02cbf492bc40abebaa93a3a208888afae72fbe06
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHRDL2 TOX ANKRD13A NDRG1 SCNN1G	5.42e-05	186	97	5	aeac0c2db173cd1ea45b5052ab418d6cacd198d8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE9A ABCA13 MAPK8IP3 PRKCQ SPAG16	5.56e-05	187	97	5	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	COVID-19-kidney-CD-PC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE9A TOX NDRG1 SCNN1G SPAG16	5.70e-05	188	97	5	8f9996c3f3b27efaaae8960a66af77412de9c7ef
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE9A ABCA13 NTRK2 LRRIQ1 PRKCQ	5.99e-05	190	97	5	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CHRDL2 LRRIQ1 SCNN1G PLCH1 L3MBTL4	6.15e-05	191	97	5	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE9A TOX NDRG1 SCNN1G SPAG16	6.30e-05	192	97	5	fd08ae787e936cfdb1ab8f19b0fd63005b462709
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE9A TOX NDRG1 SCNN1G SPAG16	6.30e-05	192	97	5	bae236c9f1fac77bce28d0a9cf090100d391ff77
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3\|TCGA-Stomach / Sample_Type by Project: Shred V9	CHRDL2 ZNF521 GLI1 CPXM1 DSE	6.61e-05	194	97	5	2260cd817a6661e5eb6645b0c6786e18fd58371e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCC4 TOX PRKCQ PLCH1 L3MBTL4	6.61e-05	194	97	5	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCC4 AADACL4 RHPN1 SCUBE2 SCNN1G	6.94e-05	196	97	5	ed76eeb37400ca154feae9b7ebaddb6c434f8b81
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 COPA PI16 CPXM1 NR1D2	6.94e-05	196	97	5	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 COPA PI16 CPXM1 NR1D2	6.94e-05	196	97	5	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17\|GI_small-bowel / Manually curated celltypes from each tissue	IL17A GPR183 NDRG1 DSE NR1D2	7.28e-05	198	97	5	f4fc0cac858fc6dcd779d7959ccec51f78ea8cc2
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHRDL2 ZNF521 TENM2 GLI2 CPXM1	7.28e-05	198	97	5	5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHRDL2 ZNF521 TENM2 GLI2 CPXM1	7.28e-05	198	97	5	ff6d9455ebfe965cc6f48197172c0ebd3bddde81
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHRDL2 ZNF521 TENM2 GLI2 CPXM1	7.28e-05	198	97	5	5375a2895cf995f0db4a61861093f01794707901
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHRDL2 ZNF521 TENM2 GLI2 CPXM1	7.28e-05	198	97	5	35edf6d5bedc2181fbdd56f43e458bc39f4eca16
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PCSK5 ABCC4 ABCA13 FSTL4 SCNN1G	7.28e-05	198	97	5	5374b0e98d669f36a0571d3c006c7bd5e3c8e87f
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TOX NTRK2 ZNF521 SCUBE2 CORIN	7.64e-05	200	97	5	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TOX NTRK2 ZNF521 SCUBE2 CORIN	7.64e-05	200	97	5	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
Disease	S-methylcysteine measurement	FMO3 FMO6P	8.79e-06	2	88	2	EFO_0800054
Disease	Acute Promyelocytic Leukemia	TET2 IL17A GLI1 GLI2	1.10e-05	46	88	4	C0023487
Disease	pappalysin‐1 measurement	PSMD2 PXDN ATXN2	8.85e-05	29	88	3	EFO_0010618
Disease	pappalysin-1 measurement	USP34 PSMD2	1.31e-04	6	88	2	EFO_0802845
Disease	Arthritis	IL17A COPA	1.31e-04	6	88	2	C0003864
Disease	human immunodeficiency virus infectious disease (is_implicated_in)	HLA-C KIR3DL1 KIR3DS1	2.17e-04	39	88	3	DOID:526 (is_implicated_in)
Disease	N-acetylcarnosine measurement	ABCC4 ATXN2	2.43e-04	8	88	2	EFO_0022101
Disease	pantothenate measurement	ABCA1 TENM2	2.43e-04	8	88	2	EFO_0021034
Disease	proteoglycan 3 measurement	USP34 PSMD2	2.43e-04	8	88	2	EFO_0802970
Disease	primary bacterial infectious disease (implicated_via_orthology)	GLI1 GLI2	3.12e-04	9	88	2	DOID:0050338 (implicated_via_orthology)
Disease	eosinophil measurement	USP34 PSMD2 PXDN ATXN2	3.12e-04	108	88	4	EFO_0803540
Disease	Tourette syndrome	PTPRU TENM2 POLR3B	4.54e-04	50	88	3	EFO_0004895
Disease	beta-2 microglobulin measurement	HLA-C ATXN2	4.75e-04	11	88	2	EFO_0005197
Disease	neutrophil count, basophil count	TET2 HLA-C PSMD2 NDRG1 ATXN2	5.66e-04	224	88	5	EFO_0004833, EFO_0005090
Disease	allergic rhinitis	DCAF1 ABCA1 CHRDL2 ATXN2	6.86e-04	133	88	4	EFO_0005854
Disease	sleep measurement	TET2 C3orf20 PXDN NFE2L1	7.26e-04	135	88	4	EFO_0004870
Disease	membranous glomerulonephritis (biomarker_via_orthology)	ABCA1 PTPRU	7.82e-04	14	88	2	DOID:10976 (biomarker_via_orthology)
Disease	lentiform nucleus measurement	FMO3 FMO6P	7.82e-04	14	88	2	EFO_0004913
Disease	beta-2-microglobulin measurement	HLA-C ATXN2	7.82e-04	14	88	2	EFO_0020180
Disease	type 1 diabetes mellitus	TOX FSTL4 ADAM30 ATXN2 PRKCQ	8.02e-04	242	88	5	MONDO_0005147
Disease	hyperinsulinism (biomarker_via_orthology)	PRKCD PRKCQ	9.00e-04	15	88	2	DOID:2018 (biomarker_via_orthology)
Disease	–	HLA-C KIR3DL1	1.03e-03	16	88	2	609423
Disease	Susceptibility to HIV infection	HLA-C KIR3DL1	1.03e-03	16	88	2	cv:C1836230
Disease	extrahepatic cholestasis (biomarker_via_orthology)	ABCC4 ABCA1	1.16e-03	17	88	2	DOID:13619 (biomarker_via_orthology)
Disease	COVID-19 (is_implicated_in)	HLA-C KIR3DS1	1.78e-03	21	88	2	DOID:0080600 (is_implicated_in)
Disease	Leukemia, Myelocytic, Acute	TET2 GPR183 FANCM PXDN	1.81e-03	173	88	4	C0023467
Disease	S-7-hydroxywarfarin to S-warfarin ratio measurement	FMO3 TOX PRKCQ	1.85e-03	81	88	3	EFO_0803334
Disease	serum metabolite measurement	ABCC4 FMO3 CDC42BPA TRPA1 HLA-C NTRK2 PSMD2 FMO6P PRKCD	2.03e-03	945	88	9	EFO_0005653
Disease	colorectal cancer	TET2 ABCC4 CHRDL2 TOX NDRG1 ATXN2 PLCH1	2.21e-03	604	88	7	MONDO_0005575
Disease	severe acute respiratory syndrome, COVID-19	NTRK2 PSMD2 TENM2 PXDN GLI2 SYT14	2.23e-03	447	88	6	EFO_0000694, MONDO_0100096
Disease	malaria (is_implicated_in)	KIR3DL1 KIR3DS1	2.33e-03	24	88	2	DOID:12365 (is_implicated_in)
Disease	Cerebral Astrocytoma	NTRK2 NDRG1	2.52e-03	25	88	2	C0750935
Disease	Intracranial Astrocytoma	NTRK2 NDRG1	2.52e-03	25	88	2	C0750936
Disease	myeloproliferative disorder	ZNF521 PSMD2	2.52e-03	25	88	2	EFO_0004251
Disease	Astrocytoma	NTRK2 NDRG1	2.52e-03	25	88	2	C0004114
Disease	Grade I Astrocytoma	NTRK2 NDRG1	2.52e-03	25	88	2	C1704230
Disease	Subependymal Giant Cell Astrocytoma	NTRK2 NDRG1	2.52e-03	25	88	2	C0205768
Disease	Mixed oligoastrocytoma	NTRK2 NDRG1	2.52e-03	25	88	2	C0547065
Disease	colon adenocarcinoma (is_marker_for)	PCSK5 TET2	2.52e-03	25	88	2	DOID:234 (is_marker_for)
Disease	Pilocytic Astrocytoma	NTRK2 NDRG1	2.52e-03	25	88	2	C0334583
Disease	Juvenile Pilocytic Astrocytoma	NTRK2 NDRG1	2.52e-03	25	88	2	C0280783
Disease	Diffuse Astrocytoma	NTRK2 NDRG1	2.52e-03	25	88	2	C0280785
Disease	Childhood Cerebral Astrocytoma	NTRK2 NDRG1	2.52e-03	25	88	2	C0338070
Disease	Gemistocytic astrocytoma	NTRK2 NDRG1	2.73e-03	26	88	2	C0334581
Disease	Protoplasmic astrocytoma	NTRK2 NDRG1	2.73e-03	26	88	2	C0334580
Disease	Fibrillary Astrocytoma	NTRK2 NDRG1	2.73e-03	26	88	2	C0334582
Disease	gout	ABCA1 NTRK2 FSTL4 ASB10	2.85e-03	196	88	4	EFO_0004274
Disease	eye measurement	ATXN2 HERC1	2.94e-03	27	88	2	EFO_0004731
Disease	Anaplastic astrocytoma	NTRK2 NDRG1	2.94e-03	27	88	2	C0334579

Protein segments in the cluster

Peptide	Gene	Start	Entry
EHYNLSAATCSPGQM	PI16	111	Q6UXB8
EPGYALQGHAHISCM	CSMD2	1936	Q7Z408
CIHSGAMPQNYQDSL	AKAP4	741	Q5JQC9
PQIMDHCFYQGSIVH	ADAM7	101	Q9H2U9
NTMDYGGHTPLHCAL	ASB10	321	Q8WXI3
IHEVHQNMGYCPQFD	ABCA1	1981	O95477
VPGSMNDFSYLHTNC	CPXM1	571	Q96SM3
VHHTSPQNAGYMQAL	ABCA13	1646	Q86UQ4
DHHSPALFQDCMNAS	AADACL4	156	Q5VUY2
DGPHVNYSQLTHFMQ	ATP2A1	861	O14983
VGHNHTYNMAPSALD	NFE2L1	571	Q14494
GVMHSNKARGYAHCQ	RAD17	501	O75943
MSSACDAGDHYPLHL	ANKRD13A	1	Q8IZ07
CMHPHNVLSDVVNYT	DCAF1	431	Q9Y4B6
LNGGDLMYHIQSCHK	PRKCQ	461	Q04759
DAVMVCSGHHVYPNL	FMO3	141	P31513
PYCSMAQAQLCFHGH	MAPK8IP3	1221	Q9UPT6
QFPCQSSMHNSHLPA	NMUR2	381	Q9GZQ4
HNYMSPTFCDHCGSL	PRKCD	236	Q05655
GAHEQTHAMYACPKL	ATXN2	1096	Q99700
PMYLHKSCHSVEDGQ	FANCM	1396	Q8IYD8
HVVCGDQLVHSPYMQ	HERC1	3871	Q15751
YNHIQLSSNLMPGCD	EIF4E	76	P06730
NMSPVTTAHAGNYTC	KIR3DL1	81	P43629
YTCHMQHEGLQEPLT	HLA-C	281	P10321
YMHCSDNTHPCQSDM	PCSK5	136	Q92824
MTAAICHDLDHPGYN	PDE9A	346	O76083
TYHDIGMNHKTCYNP	NDRG1	61	Q92597
YQCHAANMVGEAESH	IGFBPL1	241	Q8WX77
YLHNHQPTNCMALLT	DSE	201	Q9UL01
SGHHSAFGCPYSDMN	L3MBTL4	396	Q8NA19
CHQANLMSGPHSYGP	GLI1	41	P08151
MSPHACYGQVHPQLS	GLI2	1241	P10070
YPQQSHHLAASMSQE	GLI2	1321	P10070
DAVMICSGHHVYPNL	FMO6P	141	O60774
RMAAAEHCHSSGLPY	NPIPB7	216	O75200
CRGNFIPHTYCDHMS	OR52N2	171	Q8NGI0
PYHMLHGEVHCGTNV	PADI3	636	Q9ULW8
CQHNGTMYQHGEIFS	CHRDL2	111	Q6WN34
HLGCINADGNVDYHM	IL17A	96	Q16552
LSCSYGAVSNNHMHL	LRRIQ1	81	Q96JM4
HYASHMNPTLCAQLV	OR10Z1	131	Q8NGY1
LPHGSYLMVNTSQHA	PTPRU	66	Q92729
NYPHIGHTDHMVTNT	ABCC4	1296	O15439
PHQHCAVYSGGSSDM	NT5DC4	286	Q86YG4
GQVYSQPEHHAEMCF	APOBEC3F	56	Q8IUX4
GHAVGMSHDEQYCQC	ADAM30	341	Q9UKF2
LTGHNHYVMCAQFHP	COPA	131	P53621
LTVSANNCPHGMAYD	C3orf20	506	Q8ND61
MGNYTCHASGHEQLF	FSTL4	316	Q6MZW2
TPTSAFLHHQMGLCY	IFIT1B	281	Q5T764
NITHSQCQMLPYHAT	CORIN	141	Q9Y5Q5
MHFGCQAIHAQASAP	MS4A15	191	Q8N5U1
HCHYVAPLQGSSDMN	KLHDC7A	206	Q5VTJ3
SPDGHYLVSAHAMNN	HIRA	231	P54198
ECSCHPQYKMHTDGR	SCUBE2	236	Q9NQ36
HHPMHGNCYTFNNRE	SCNN1G	276	P51170
LGMAYSNCQHDFQAP	MICOS10	51	Q5TGZ0
CKGNVIPHTYCDHMS	OR52N1	171	Q8NH53
NIMHYPNGHAICIAN	NR1D2	326	Q14995
NVTNCTVMHLHPYTA	USH2A	2581	O75445
LEPSYNHSGCDSQMS	SYT14	381	Q8NB59
YGHVAACQLMGPHTL	PLEKHH3	706	Q7Z736
MAHHPVITNGAYNSL	TBR1	146	Q16650
HAGYPIMCHLESVQE	TCAF1	726	Q9Y4C2
IVPYNMAHNAEHEAC	PSMD2	191	Q13200
QTMGSLQPLCHSDYD	TAF1	126	P21675
LYCMSDHFHAEQGSP	TDRD12	766	Q587J7
PQGNDCDLYAHHSTA	GPR183	16	P32249
NMSPVTTAHAGNYTC	KIR3DS1	81	Q14943
PHRSGYCSDMGILHQ	TENM2	91	Q9NT68
NGEGNPYSMLHSNDH	CDC42BPA	1386	Q5VT25
HYHVAMALCDGSPAT	RHPN1	356	Q8TCX5
HNEGYSSMCGHAVLA	L3HYPDH	96	Q96EM0
YQNALTACHMDSSPQ	CNNM1	786	Q9NRU3
EYHGCLQLDNPTHMN	NTRK2	341	Q16620
LHEMDDYGNTPLHCA	TRPA1	91	O75762
DVLEHHMDPSSNFCN	RASGEF1A	341	Q8N9B8
HSCHAMLYAANPGQL	NUDT16L1	26	Q9BRJ7
YSHMDSHQQPESCNH	ZNF521	326	Q96K83
ICEQSLYGHMHSIND	SPAG16	511	Q8N0X2
YRTHDGTCNNLQHPM	PXDN	741	Q92626
NFAHVTSLGYCHGME	ZNF551	61	Q7Z340
LPHLQSMGYHCSNTG	NFATC3	876	Q12968
HHNQSPRNTYQCAMG	POLR3B	676	Q9NW08
PSCCFTIYHGNHMES	PLCH1	91	Q4KWH8
CGMVFPQNSHLASHQ	ZNF347	266	Q96SE7
HMNISTVERPYGCHE	ZNF140	151	P52738
HHSSERPYMCNECGK	ZNF16	286	P17020
HFRQLCYHEMSGPQE	ZKSCAN7	56	Q9P0L1
DCGQMFSQSSHLVPH	ZNF594	271	Q96JF6
NHCTYHHSNIPMSLG	USP34	3076	Q70CQ2
SHPTTSHMGEFCNQE	TEX15	1116	Q9BXT5
SHMGEFCNQEHPESQ	TEX15	1121	Q9BXT5
HIIHNYSAAPGMFNS	TET2	1761	Q6N021
LNEVESGYHSLCHPM	TOX	86	O94900
SGYHSLCHPMNHNGL	TOX	91	O94900
HMNSHTGEKPYGCDL	ZNF317	436	Q96PQ6
YPSCLNNHMRTHSAQ	ZNF426	431	Q9BUY5
HQSTHTGEKPYECMN	ZNF181	311	Q2M3W8
DNCHSTPLHVAEYML	AGL	526	P35573